Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
5,856
datasets available to search
ShareScore release 0.9.0
Dataset results
5,856 results for “B cells”
Combination of Inaticabtagene Autoleucel With Autologous Hematopoietic Stem Cell Transplantation for Adolescents or Adults With MRD-Positive B-Cell Acute Lymphoblastic Leukemia in Initial Complete Rem
ClinicalTrials.gov study NCT06608732. IPD Sharing: NO. Countries: 1. Publications: 0.
The Clinical Application of Chimeric Antigen Receptor T Cells in the Treatment of CD19 Positive Recurrent Refractory B Cell-derived Hematological Malignancies
ClinicalTrials.gov study NCT04184414. IPD Sharing: NO. Countries: 1. Publications: 0.
αβT Cell/CD19+ B Cell Depletion for Alternative Donor Allogeneic Hematopoietic Cell Transplantation (HSCT)
ClinicalTrials.gov study NCT06082947. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Real Time Molecular Characterization of Diffuse Large B Cell Lymphoma (DLBCL)
ClinicalTrials.gov study NCT03104478. IPD Sharing: NO. Countries: 1. Publications: 0.
Transplantation With Ybritumomab Tiuxetan (Zevalin) Plus BEAM Regimen in Patients With Refractory Large B-cell Difusse Lymphom
ClinicalTrials.gov study NCT00646750. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase 1/2 Study of T-cell Expressing an Anti-CD22 Chimeric-Antigen Receptor (SHB-04-CD22) in Patients With CD22-expressing B-cell Malignancies
ClinicalTrials.gov study NCT07135466. IPD Sharing: YES. Countries: 1. Publications: 0.
B Cell Differentiation in MS
ClinicalTrials.gov study NCT03744351. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Chidamide Plus R-CHOP in Newly Diagnosed Double-Expressor Diffuse Large B-Cell Lymphoma With Other Molecular Subtypes
ClinicalTrials.gov study NCT06891157. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Ublituximab in Combination With Lenalidomide in Patients With B-Cell Lymphoid Malignancies
ClinicalTrials.gov study NCT01744912. IPD Sharing: NO. Countries: 1. Publications: 0.
Indication to Transplant Patients With High Risk B Cells Lymphoma in Metabolic Complete Remission?
ClinicalTrials.gov study NCT03681938. IPD Sharing: NO. Countries: 1. Publications: 0.
The Use of PET for the Early Response Evaluation in Patients With Diffuse Large B-cell Lymphoma.
ClinicalTrials.gov study NCT01865058. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Predictive Biomarkers Including miRNA-based Tumor Signatures in Diffuse Large B Cell Lymphoma (R/R DLBCL) (MIMOSA)
ClinicalTrials.gov study NCT05746858. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
A Study to Evaluate Zilovertamab Vedotin (MK-2140) for Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL) (MK-2140-004)
ClinicalTrials.gov study NCT05144841. IPD Sharing: YES. Countries: 17. Publications: 0.
A Study of CNTY-101 in Participants With Refractory B Cell-mediated Autoimmune Diseases
ClinicalTrials.gov study NCT06255028. IPD Sharing: NO. Countries: 1. Publications: 0.
Clonal Evolution of B Cells in High-risk CLL After Idelalisib-rituximab
ClinicalTrials.gov study NCT02993536. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Rituximab Augmentation Following R-CHOP Induction Chemotherapy in Extremely Elderly Patients With Diffuse Large B Cell Lymphoma
ClinicalTrials.gov study NCT01181999. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Tafasitamab, Retifanlimab, and Rituximab in Combination With Standard Therapy for the Treatment of Diffuse Large B-cell Lymphoma
ClinicalTrials.gov study NCT05455697. IPD Sharing: NO. Countries: 1. Publications: 0.
Safety and Pharmacokinetic Study of IMM0306 in Patients With Refractory or Relapsed CD20-positive B-cell Non-Hodgkin's Lymphoma (B-NHL)
ClinicalTrials.gov study NCT04746131. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Selinexor in Combination With Backbone Treatments or Novel Therapies In Participants With Relapsed or Refractory (RR) Diffuse Large B-Cell Lymphoma (DLBCL)
ClinicalTrials.gov study NCT04607772. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
CD22-CAR T Cells in Children and Young Adults With B Cell Malignancies
ClinicalTrials.gov study NCT04088864. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.